Soluble interleukin-2 receptor in cancer
Copyright policy )Soluble interleukin-2 receptor in cancer
Levels of serum sIL-2R (soluble interleukin-2 receptor) reflect the total amount of activated T lymphocytes in tumor infiltrating lymphocytes of cancer tissues and metastatic organs, because a part of alpha-chain of IL-2R is released into the bloodstream on the attachment of IL-2 (interleukin-2) to its specific IL-2R membrane. In most malignant diseases, elevated levels of serum sIL-2R are found, compare to normal control. Serum sIL-2R is a useful parameter for evaluating the disease stage and monitoring the disease progression during the post-treatment follow-up, though it is not an organ-specific parameter.
Male, Receptors, Interleukin-2, Gene Expression Regulation, Neoplastic, Lymphocytes, Tumor-Infiltrating, Neoplasms, Biomarkers, Tumor, Disease Progression, Humans, Interleukin-2, Female
Male, Receptors, Interleukin-2, Gene Expression Regulation, Neoplastic, Lymphocytes, Tumor-Infiltrating, Neoplasms, Biomarkers, Tumor, Disease Progression, Humans, Interleukin-2, Female
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).55 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!